Royal Bank of Canada’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$119M Buy
543,757
+20,620
+4% +$4.51M 0.02% 520
2025
Q1
$117M Sell
523,137
-2,351
-0.4% -$526K 0.02% 476
2024
Q4
$172M Buy
525,488
+72,548
+16% +$23.8M 0.03% 368
2024
Q3
$136M Buy
452,940
+44,804
+11% +$13.4M 0.03% 426
2024
Q2
$134M Buy
408,136
+79,660
+24% +$26.2M 0.03% 408
2024
Q1
$130M Sell
328,476
-13,221
-4% -$5.23M 0.03% 399
2023
Q4
$120M Buy
341,697
+12,752
+4% +$4.49M 0.03% 421
2023
Q3
$123M Sell
328,945
-11,183
-3% -$4.2M 0.03% 378
2023
Q2
$130M Buy
340,128
+2,783
+0.8% +$1.06M 0.03% 379
2023
Q1
$117M Buy
337,345
+65,458
+24% +$22.7M 0.03% 390
2022
Q4
$64M Sell
271,887
-1,657
-0.6% -$390K 0.02% 542
2022
Q3
$67.3M Sell
273,544
-890
-0.3% -$219K 0.02% 503
2022
Q2
$83M Buy
274,434
+19,658
+8% +$5.94M 0.02% 455
2022
Q1
$105M Sell
254,776
-53,375
-17% -$21.9M 0.03% 430
2021
Q4
$145M Sell
308,151
-21,465
-7% -$10.1M 0.03% 375
2021
Q3
$140M Sell
329,616
-71,893
-18% -$30.5M 0.04% 355
2021
Q2
$144M Buy
401,509
+94,707
+31% +$34M 0.04% 353
2021
Q1
$86.5M Buy
306,802
+5,656
+2% +$1.59M 0.03% 452
2020
Q4
$85.3M Sell
301,146
-14,242
-5% -$4.03M 0.02% 433
2020
Q3
$86.7M Sell
315,388
-14,859
-4% -$4.08M 0.03% 367
2020
Q2
$75M Buy
330,247
+15,431
+5% +$3.51M 0.03% 388
2020
Q1
$47.9M Sell
314,816
-15,784
-5% -$2.4M 0.02% 453
2019
Q4
$49.7M Sell
330,600
-10,447
-3% -$1.57M 0.02% 536
2019
Q3
$48.4M Sell
341,047
-26,577
-7% -$3.77M 0.02% 511
2019
Q2
$46M Sell
367,624
-39,073
-10% -$4.89M 0.02% 536
2019
Q1
$44.8M Sell
406,697
-57,661
-12% -$6.35M 0.02% 521
2018
Q4
$45.5M Sell
464,358
-138,250
-23% -$13.6M 0.02% 459
2018
Q3
$74.4M Sell
602,608
-33,430
-5% -$4.13M 0.03% 374
2018
Q2
$63.2M Sell
636,038
-45,262
-7% -$4.49M 0.03% 405
2018
Q1
$60.2M Sell
681,300
-31,551
-4% -$2.79M 0.03% 431
2017
Q4
$70.3M Sell
712,851
-94,345
-12% -$9.31M 0.03% 379
2017
Q3
$77.7M Sell
807,196
-21,589
-3% -$2.08M 0.04% 336
2017
Q2
$78.3M Sell
828,785
-63,601
-7% -$6.01M 0.04% 324
2017
Q1
$72.8M Buy
892,386
+53,447
+6% +$4.36M 0.04% 328
2016
Q4
$71.2M Sell
838,939
-43,322
-5% -$3.67M 0.04% 331
2016
Q3
$65.7M Sell
882,261
-572,942
-39% -$42.7M 0.04% 340
2016
Q2
$110M Sell
1,455,203
-109,240
-7% -$8.29M 0.07% 218
2016
Q1
$108M Buy
1,564,443
+8,075
+0.5% +$560K 0.07% 204
2015
Q4
$93.7M Sell
1,556,368
-34,344
-2% -$2.07M 0.06% 225
2015
Q3
$86.1M Buy
1,590,712
+7,090
+0.4% +$384K 0.06% 185
2015
Q2
$92M Sell
1,583,622
-56,716
-3% -$3.29M 0.06% 202
2015
Q1
$98.8M Sell
1,640,338
-107,811
-6% -$6.49M 0.07% 186
2014
Q4
$93.1M Buy
1,748,149
+161,750
+10% +$8.61M 0.06% 215
2014
Q3
$71M Buy
1,586,399
+57,487
+4% +$2.57M 0.05% 240
2014
Q2
$64.5M Buy
1,528,912
+91,445
+6% +$3.86M 0.04% 265
2014
Q1
$63.3M Buy
1,437,467
+20,194
+1% +$890K 0.05% 259
2013
Q4
$69.5M Buy
1,417,273
+114,757
+9% +$5.63M 0.05% 246
2013
Q3
$53.6M Buy
1,302,516
+176,120
+16% +$7.25M 0.04% 273
2013
Q2
$39.6M Buy
+1,126,396
New +$39.6M 0.03% 335